---
title: "JMPT's equity distribution for the first three quarters: a dividend of 2.17 yuan for every 10 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225019788.md"
description: "According to the announcement released by JMPT, the equity distribution plan for the first three quarters of 2024 is as follows: based on the company's existing total shares, a cash dividend of RMB 2.17 (including tax) will be distributed for every 10 shares to all shareholders. The equity registration date is January 21, 2025, and the ex-dividend date is January 22, 2025"
datetime: "2025-01-15T08:55:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225019788.md)
  - [en](https://longbridge.com/en/news/225019788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225019788.md)
generator: "portal-rs"
---

# JMPT's equity distribution for the first three quarters: a dividend of 2.17 yuan for every 10 shares

According to the announcement from JMPT (000700.SZ), the equity distribution plan for the first three quarters of 2024 is as follows: based on the company's existing total shares, a cash distribution of RMB 2.17 (including tax) will be paid for every 10 shares to all shareholders. The equity registration date is January 21, 2025, and the ex-dividend date is January 22, 2025

### Related Stocks

- [000700.CN](https://longbridge.com/en/quote/000700.CN.md)

## Related News & Research

- [FOCUS-Why Dutch insurers remain on the sidelines as Netherlands pushes defence spending](https://longbridge.com/en/news/296733242.md)
- [After gaining EV sway, Chinese carmakers eye full hybrid market](https://longbridge.com/en/news/296736607.md)
- [Flughafen Wien (WBAG:FLU) Q2 Earnings Put Valuation Back In Focus](https://longbridge.com/en/news/296706534.md)
- [Dino Polska S.A. (WSE:DNP) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296763667.md)
- [Flexcon Announces Global Relaunch of PharmCal® BioMark with ISEGA Certification](https://longbridge.com/en/news/296800649.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**